Transapical Transcatheter Mitral Valve Replacement After Failed Transcatheter Edge-to-Edge Repair
JACC: Cardiovascular Interventions · 2025
DOI: 10.1016/j.jcin.2024.10.018 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Daryoush Samim und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Bern University Hospital, Bern, Switzerland. Electronic address: https://twitter.com/DaryoushSamim. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation, Cardiac Catheterization, Mitral Valve. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Management of recurrent mitral regurgitation (MR) or relevant iatrogenic mitral valve (MV) stenosis after mitral transcatheter edge-to-edge repair (M-TEER) emerges as an increasingly relevant clinical issue. Surgery after M-TEER is associated with higher morbidity and mortality. Electrosurgical leaflet laceration and stabilization of the implant (ELASTA-Clip) followed by transcatheter mitral valve replacement (TMVR) is an innovative, less-invasive treatment option for patients with TEER failure. OBJECTIVES: The authors sought to evaluate the early results of ELASTA-Clip followed by transapical TMVR in patients with symptomatic failed M-TEER (defined as persistent or recurrent MR, or iatrogenic MV stenosis). METHODS: Data from symptomatic patients with failed M-TEER who underwent ELASTA-Clip followed by compassionate use or commercial transapical TMVR using the Abbott Tendyne system were retrospectively collected from 8 tertiary care centers in 4 countries. Safety and efficacy of the procedure were assessed up to 1 year according to Mitral Valve Academic Research Consortium (MVARC) criteria. RESULTS: A total of 22 patients (mean age 77.8 ± 9.2 years, 40.9% [9/22] female) at high surgical risk (EuroSCORE II 8.0 ± 0.4, STS score 7.2% ± 1.1%) with symptomatic residual MR ≥3+ (n = 21) or iatrogenic MV stenosis (n = 1) after failed M-TEER were followed for a median period of 8.5 [Q1-Q3: 2.6-11.6] months. The ELASTA-Clip procedure (90.9% [20/22] transseptal, 9.1% [2/22] transapical) followed by TMVR were successful in all patients (22/22). Technical success according to MVARC was achieved in 21 patients (21/22, 95.4%) without left ventricular outflow tract obstruction or conversion to sternotomy. At 30 days, 3 patients had paravalvular leak progression, ischemic stroke occurred in 3 patients (3/20, 15.0%). Baseline MR (≥3+ in 95.5% [21/22]) was reduced to grade 1+ or less in all patients with durable results in 89.5% (17/19) (P < 0.001). NYHA functional class significantly improved to ≤II in 81.3% (13/16) at discharge (P < 0.001) and 72.2% (13/18) at last follow-up (P < 0.001). At 30 days, all patients (20/20) were alive. Three patients (3/20, 15.0%) were rehospitalized for heart failure (uncontrolled atrial fibrillation in 2 cases) and 1 of them (1/22, 4.5%) underwent a reintervention (valve retensioning). CONCLUSIONS: Transapical TMVR after ELASTA-Clip is a feasible and less invasive option for the management of failed M-TEER that can be performed with acceptable results in a carefully selected patient population. Particular attention is required to avoid paravalvular leakage and measures to minimize the risk of periprocedural cerebrovascular events need to be implemented in future larger-scale prospective studies with longer-term follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Bern University Hospital, Bern, Switzerland. Electronic address: https://twitter.com/DaryoushSamim.
- Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
- Department of Cardiology, Bern University Hospital, Bern, Switzerland.
- Medizinische Klinik und Poliklinik I, LMU University Hospital, Munich, Germany.
- Department of Cardiology, Bern University Hospital, Bern, Switzerland; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
- Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, School of Medicine & Health, Technical University of Munich, Germany.
Zitieren
APA
Samim, D., Sorajja, P., Lanz, J., Stolz, L., Angellotti, D., Hausleiter, J., Ruge, H., Kuhn, E. W., Baldus, S., Ochs, L., Ueyama, H. A., Babaliaros, V., Greenbaum, A. B., Gössl, M., Januska, J., Alreshidan, M., Reineke, D., Windecker, S., Adam, M., & Praz, F. (2025). Transapical Transcatheter Mitral Valve Replacement After Failed Transcatheter Edge-to-Edge Repair. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.10.018
Vancouver
Samim D, Sorajja P, Lanz J, Stolz L, Angellotti D, Hausleiter J, et al. Transapical Transcatheter Mitral Valve Replacement After Failed Transcatheter Edge-to-Edge Repair. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2024.10.018
BibTeX
@article{Samim2025,
author = {Samim, Daryoush and Sorajja, Paul and Lanz, Jonas and Stolz, Lukas and Angellotti, Domenico and Hausleiter, Jörg and Ruge, Hendrik and Kuhn, Elmar W and Baldus, Stephan and Ochs, Laurin and Ueyama, Hiroki A and Babaliaros, Vasilis and Greenbaum, Adam B and Gössl, Mario and Januska, Jaroslav and Alreshidan, Mohammad and Reineke, David and Windecker, Stephan and Adam, Matti and Praz, Fabien},
title = {Transapical Transcatheter Mitral Valve Replacement After Failed Transcatheter Edge-to-Edge Repair},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
doi = {10.1016/j.jcin.2024.10.018}
}
EUVIMED